Home > Insider Trading > Filing (0001140361-20-020798)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1484612	Outset Medical Inc.	OM	Electromedical & Electrotherapeutic Apparatus (3845)	200514392

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1823381	L. John Brottem	3052 Orchard Drive San Jose CA 95134	General Counsel	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-09-17	2,500	$27.00	2,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2020-05-26	67,898	$0.00	67,898	$9.48
Common Stock	Performance Stock Option (Right to Buy)	Acquisiton	2020-05-26	45,265	$0.00	45,265	$9.48

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
67,898		2030-05-26	No	4	A	Direct
45,265		2030-05-26	No	4	A	Direct

Footnotes

This option vests 25% on May 26, 2021, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lock-up period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event.
This option has been adjusted to reflect the 1-for-7.9 reverse stock split that occurred on September 8, 2020.
This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.